🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was designed to evaluate the ability of AI-700-enhanced rest-str...
Status
Completed
Location
Acusphere, Inc.
Start Date
2003-12
Trial ID
NCT00156793
Treatments Being Tested
This study will be divided into 2 parts (Part 1 and Part 2). Part 1 will ev...
Status
Active Not Recruiting
Location
University of California, Los Angeles
Start Date
2025-01-14
Trial ID
NCT06456463
Treatments Being Tested
This Phase 3 multinational, randomized, double-blind study is designed to c...
Status
Completed
Location
The University of Arizona Cancer Centre-North Campus
Start Date
2017-06-19
Trial ID
NCT03112174
Treatments Being Tested
Parkinson's disease (PD) is a prevalent neurodegenerative disorder characte...
Status
Recruiting
Location
Universitätsklinikum Hamburg-Eppendorf
Start Date
2025-04-16
Trial ID
NCT06993571
Treatments Being Tested
Venetoclax and ibrutinib have complementary activity in clearing the diseas...
Status
Terminated
Location
Kantonsspital Aarau
Start Date
2019-03-11
Trial ID
NCT03708003
Treatments Being Tested
Many individuals with schizophrenia struggle with auditory verbal hallucina...
Status
Unknown
Location
Royal Ottawa Mental Health Centre
Start Date
2019-01-01
Trial ID
NCT04222582
Treatments Being Tested
This is a multicenter, open-label, Phase 1/2a dose escalation and expansion...
Status
Suspended
Location
Moffitt Cancer Center
Start Date
2020-07-06
Trial ID
NCT04278768
Treatments Being Tested
The main objective of this study is to evaluate the efficacy of the combina...
Status
Completed
Location
Dana-Farber Cancer Institute /ID# 207728
Start Date
2020-01-14
Trial ID
NCT03873493
Treatments Being Tested
BTK inhibitors and BCL-2 inhibitors have demonstrated significant clinical ...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Start Date
2026-07-14
Trial ID
NCT07609862
Treatments Being Tested